Scholarly Index
Francesco Cappelli
Azienda Ospedaliero-Universitaria Careggi; 5,448 total citations; 269 total publications; best world rank #15
Azienda Ospedaliero-Universitaria Careggi
5,448Total citations
269Total publications
38H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Amyloidosis: Diagnosis, Treatment, Outcomes | Lifetime | 297 | IT 18 | 96.42 |
| Parathyroid Disorders and Treatments | Lifetime | 624 | IT 36 | 96.48 |
| Takotsubo Cardiomyopathy and Associated Phenomena | Lifetime | 687 | IT 70 | 78.76 |
| Parathyroid Disorders and Treatments | 2021-2025 | 15 | IT 6 | 99.08 |
| Amyloidosis: Diagnosis, Treatment, Outcomes | 2021-2025 | 27 | IT 9 | 98.76 |
| Peptidase Inhibition and Analysis | 2021-2025 | 184 | IT 11 | 95.83 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 843 | IT 110 | 94.75 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 597 | IT 88 | 88.12 |
| Sarcoidosis and Beryllium Toxicity Research | 2021-2025 | 366 | IT 34 | 84.50 |
| Medical Imaging and Pathology Studies | 2021-2025 | 906 | IT 63 | 73.81 |
| Cellular transport and secretion | 2021-2025 | 828 | IT 36 | 71.80 |
| Takotsubo Cardiomyopathy and Associated Phenomena | 2021-2025 | 320 | IT 57 | 63.42 |
| Dermatological and Skeletal Disorders | 2021-2025 | 595 | IT 91 | 50.93 |
| Studies on Chitinases and Chitosanases | 2021-2025 | 816 | IT 36 | 26.16 |